MX2010008922A - Compuestos antibioticos azatriciclicos. - Google Patents
Compuestos antibioticos azatriciclicos.Info
- Publication number
- MX2010008922A MX2010008922A MX2010008922A MX2010008922A MX2010008922A MX 2010008922 A MX2010008922 A MX 2010008922A MX 2010008922 A MX2010008922 A MX 2010008922A MX 2010008922 A MX2010008922 A MX 2010008922A MX 2010008922 A MX2010008922 A MX 2010008922A
- Authority
- MX
- Mexico
- Prior art keywords
- antibiotic compounds
- azatricyclic
- azatricyclic antibiotic
- represent
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/16—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/16—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La invención se refiere a compuestos antibacteriales de fórmula I (I) caracterizados porque n es 0 ó 1; R1 representa H o F; U representa CH2 o, cuando n es 1, 0 o NH; "-----" es un enlace o está ausente; V representa CH o N cuando "-----" es un enlace, o CH2 o NH cuando "-----" está ausente; W representa CH o N; A representa -(CH2)p-NH-(CH2)q- caracterizado porque p es 1 y q es 1 ó 2 o, cuando U representa CH2 y n es 1, p también puede ser 0 y q entonces es 2; G representa uno de los grupos caracterizados porque Z representa N o CH y Q representa O o S; y Z0, Z1 y Z2 cada uno representa CH, o Z0 y Z1 cada uno representa CH y Z2 representa N, o Z0 representa CH, Z1 representa N y Z2 representa CH o N, o Z0 representa N y Z1 y Z2 cada uno representa CH; y con sales de tales compuestos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IB2008050603 | 2008-02-20 | ||
IB2008054065 | 2008-10-03 | ||
PCT/IB2009/050675 WO2009104147A2 (en) | 2008-02-20 | 2009-02-19 | Azatricyclic antibiotic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010008922A true MX2010008922A (es) | 2010-09-07 |
Family
ID=40986002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010008922A MX2010008922A (es) | 2008-02-20 | 2009-02-19 | Compuestos antibioticos azatriciclicos. |
Country Status (14)
Country | Link |
---|---|
US (1) | US8349828B2 (es) |
EP (1) | EP2257551B1 (es) |
JP (1) | JP5349500B2 (es) |
KR (1) | KR101590202B1 (es) |
CN (1) | CN102015710B (es) |
AR (1) | AR070455A1 (es) |
AU (1) | AU2009215327A1 (es) |
BR (1) | BRPI0907892A2 (es) |
CA (1) | CA2713182C (es) |
ES (1) | ES2411930T3 (es) |
MX (1) | MX2010008922A (es) |
RU (1) | RU2010138648A (es) |
TW (1) | TW200940551A (es) |
WO (1) | WO2009104147A2 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009104147A2 (en) | 2008-02-20 | 2009-08-27 | Actelion Pharmaceuticals Ltd | Azatricyclic antibiotic compounds |
PT2344495E (pt) * | 2008-10-07 | 2015-04-01 | Actelion Pharmaceuticals Ltd | Compostos antibióticos de oxazolidinona tricíclica |
EP2346862B1 (en) * | 2008-10-10 | 2012-09-12 | Actelion Pharmaceuticals Ltd. | 2-benzothiophenyl-and 2-naphthyl-0xaz0lidin0nes and their azaisostere analogues as antibacterial agents |
JPWO2012108376A1 (ja) | 2011-02-07 | 2014-07-03 | 第一三共株式会社 | アミノ基含有ピロリジノン誘導体 |
EP2726489A1 (en) * | 2011-06-30 | 2014-05-07 | DSM IP Assets B.V. | Silicone-containing monomer |
BR112014003200A2 (pt) | 2011-08-11 | 2017-04-04 | Actelion Pharmaceuticals Ltd | derivados de quinazolina-2,4-diona |
TW201326180A (zh) | 2011-11-30 | 2013-07-01 | Actelion Pharmaceuticals Ltd | 3,7-二取代八氫-2H-吡啶并[4,3-e][1,3]□嗪-2-酮抗生素 |
WO2014024056A1 (en) | 2012-08-06 | 2014-02-13 | Daiichi Sankyo Company, Limited | Pyrrolidine derivatives with antibacterial properties |
EA029361B1 (ru) | 2013-04-16 | 2018-03-30 | Идорсиа Фармасьютиклз Лтд | Антибактериальные биароматические производные |
ITMI20131782A1 (it) * | 2013-10-25 | 2015-04-26 | Dipharma Francis Srl | Procedimento per la preparazione di un agonista della trombopoietina |
JP6112724B2 (ja) * | 2013-10-31 | 2017-04-12 | 日本化薬株式会社 | 1,5−ナフチリジン誘導体およびそれを有効成分として含んでなる殺虫剤 |
AR102256A1 (es) | 2014-10-15 | 2017-02-15 | Actelion Pharmaceuticals Ltd | Derivados biaromáticos básicos antibacterianos con sustitución de aminoalcoxi |
TW201833120A (zh) | 2017-02-17 | 2018-09-16 | 瑞士商愛杜西亞製藥有限公司 | 芳基噁唑啶酮抗生素化合物 |
JP7390728B2 (ja) | 2017-11-29 | 2023-12-04 | バグワークス・リサーチ・インコーポレイテッド | 抗菌複素環式化合物及びそれらの合成 |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5746987A (en) * | 1980-09-05 | 1982-03-17 | Mitsubishi Chem Ind Ltd | 3,4-dihydrocarbostyril derivative and agricultural and horticultural germicide containing the same as active constituent |
IT1212552B (it) | 1982-10-20 | 1989-11-30 | Italo Britannica L Manet Ti H | Alcanolaminossi derivati di 3,4-diidro-2h-1.4-benzotiazin-3-one, loro procedimento di produzione e loro utilizzazione farmaceutica |
US5298518A (en) | 1989-09-29 | 1994-03-29 | Eisai Co., Ltd. | Biphenylmethane derivative and pharmacological use |
US5254682A (en) | 1989-12-08 | 1993-10-19 | Merck & Co., Inc. | Cyclic renin inhibitors containing 3(S)-amino-4-cyclohexyl-2(R)-hydroxy-butanoic acid or 4-cyclo-hexyl-(2R, 3S)-dihydroxybutanoic acid or related analogs |
EP0934326B1 (de) | 1996-10-24 | 2006-05-03 | Novartis AG | Substituierte aminoalkanphosphonsäuren |
WO2001030782A2 (en) | 1999-10-29 | 2001-05-03 | Syngenta Participations Ag | Novel herbicides |
AR040336A1 (es) | 2002-06-26 | 2005-03-30 | Glaxo Group Ltd | Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto |
WO2005016883A2 (en) | 2003-08-14 | 2005-02-24 | Icos Corporation | Acrylamide derivatives as vla-1 integrin antagonists and uses thereof |
FR2873695A1 (fr) * | 2004-07-30 | 2006-02-03 | Palumed Sa | Molecules hybrides qa ou q est une aminoquinoleine et a est un antibiotique ou un inhibiteur de resistance), leur synthese et leurs utilisations en tant qu'agent antibacterien |
AU2005279050A1 (en) * | 2004-07-30 | 2006-03-09 | Centre National De La Recherche Scientifique (Cnrs) | Hybrid molecules QA where Q is an aminoquinoline and A is an antibiotic residue, and the synthesis and uses thereof as antibacterial agents |
DE102004041163A1 (de) | 2004-08-25 | 2006-03-02 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
WO2006032466A2 (en) | 2004-09-24 | 2006-03-30 | Actelion Pharmaceuticals Ltd | New bicyclic antibiotics |
WO2006046552A1 (ja) | 2004-10-27 | 2006-05-04 | Toyama Chemical Co., Ltd. | 新規な含窒素複素環化合物およびその塩 |
US20090131444A1 (en) | 2005-05-24 | 2009-05-21 | Astrazeneca Ab | Aminopiperidine Quinolines and Their Azaisosteric Analogues with Antibacterial Activity |
WO2007016610A2 (en) | 2005-08-02 | 2007-02-08 | Glaxo Group Limited | Antibacterial agents |
DE602006012535D1 (de) | 2005-10-21 | 2010-04-08 | Glaxo Group Ltd | Peri-kondensierte tricyclische verbindungen verwendbar als antibakterielle mittel |
ATE465163T1 (de) * | 2005-12-22 | 2010-05-15 | Glaxo Group Ltd | Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel |
CA2642406A1 (en) * | 2006-02-14 | 2007-08-23 | Pfizer Products Inc. | Benzoxazinone and benzoxazepinone oxazolidinones as antibacterial agents |
TW200804336A (en) | 2006-03-23 | 2008-01-16 | Actelion Pharmaceuticals Ltd | Cyclohexyl or piperidinyl carboxamide antibiotic derivatives |
US7709483B2 (en) | 2006-04-06 | 2010-05-04 | Glaxo Group Limited | Pyrrolo-quinoxalinone derivatives as antibacterials |
GB0608263D0 (en) | 2006-04-26 | 2006-06-07 | Glaxo Group Ltd | Compounds |
AU2007259257B8 (en) | 2006-06-16 | 2012-04-05 | Pharma Mar, S.A. | Antitumoral dihydropyran-2-one compounds |
GB0613208D0 (en) | 2006-07-03 | 2006-08-09 | Glaxo Group Ltd | Compounds |
TW200819457A (en) | 2006-08-30 | 2008-05-01 | Actelion Pharmaceuticals Ltd | Spiro antibiotic derivatives |
ATE495743T1 (de) | 2006-12-01 | 2011-02-15 | Galapagos Nv | Triazolopyridinverbindungen zur behandlung von degenerations- und entzündungskrankheiten |
CL2007003693A1 (es) | 2006-12-22 | 2008-06-27 | Actelion Pharmaceuticals Ltd | Compuestos derivados de pirido [3,2-b] [1,4] tiazina; composicion farmaceutica que contiene dichos compuestos; y su uso en el tratamiento de infecciones bacterianas. |
GB0705672D0 (en) | 2007-03-23 | 2007-05-02 | Glaxo Group Ltd | Compounds |
JPWO2008120655A1 (ja) | 2007-03-30 | 2010-07-15 | 株式会社医薬分子設計研究所 | I型11βヒドロキシステロイド脱水素酵素阻害活性を有するオキサゾリジノン誘導体 |
WO2008120003A1 (en) | 2007-04-03 | 2008-10-09 | Astrazeneca Ab | Substituted piperidines for use in the treatment of bacterial infections |
CL2008001003A1 (es) | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. |
CL2008001002A1 (es) | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. |
EP1980251A1 (en) | 2007-04-13 | 2008-10-15 | Glaxo Group Limited | Pyrrolo[3,2,1-ij]quinoline-4-one derivatives for treating tuberculosis |
KR101567096B1 (ko) | 2007-04-20 | 2015-11-06 | 글락소 그룹 리미티드 | 항균제로서의 트리시클릭 질소 함유 화합물 |
GB0707708D0 (en) | 2007-04-20 | 2007-05-30 | Glaxo Group Ltd | Compounds |
GB0707706D0 (en) | 2007-04-20 | 2007-05-30 | Glaxo Group Ltd | Compounds |
EP2154965A4 (en) | 2007-05-29 | 2011-08-17 | Glaxosmithkline Llc | NAPHTHYRIDINE DERIVATIVES AS P13 KINASE INHIBITORS |
AR066879A1 (es) | 2007-06-08 | 2009-09-16 | Novartis Ag | Derivados de quinoxalina como inhibidores de la actividad de cinasa de tirosina de las cinasas janus |
MX2009013254A (es) | 2007-06-15 | 2010-01-25 | Actelion Pharmaceuticals Ltd | Derivados 3-amino-6(1-amino-etil)-tetrahidropirano. |
EP2005995A1 (en) | 2007-06-22 | 2008-12-24 | Glaxo Group Limited | Heterocyclic compounds for the treatment of tuberculosis |
MX2010006111A (es) | 2007-12-18 | 2010-06-25 | Actelion Pharmaceuticals Ltd | Derivados de 5-aminociclilmetil-oxazolidin-2-ona y su uso como antibacteriales. |
GB0800367D0 (en) | 2008-01-09 | 2008-02-20 | Glaxo Group Ltd | Compounds |
WO2009104147A2 (en) | 2008-02-20 | 2009-08-27 | Actelion Pharmaceuticals Ltd | Azatricyclic antibiotic compounds |
US8349826B2 (en) | 2008-02-22 | 2013-01-08 | Actelion Pharmaceuticals Ltd. | Oxazolidinone derivatives |
-
2009
- 2009-02-19 WO PCT/IB2009/050675 patent/WO2009104147A2/en active Application Filing
- 2009-02-19 JP JP2010547289A patent/JP5349500B2/ja not_active Expired - Fee Related
- 2009-02-19 KR KR1020107019907A patent/KR101590202B1/ko active IP Right Grant
- 2009-02-19 BR BRPI0907892-4A patent/BRPI0907892A2/pt not_active IP Right Cessation
- 2009-02-19 TW TW098105338A patent/TW200940551A/zh unknown
- 2009-02-19 EP EP09712156.0A patent/EP2257551B1/en not_active Not-in-force
- 2009-02-19 MX MX2010008922A patent/MX2010008922A/es not_active Application Discontinuation
- 2009-02-19 AU AU2009215327A patent/AU2009215327A1/en not_active Abandoned
- 2009-02-19 CN CN2009801060558A patent/CN102015710B/zh not_active Expired - Fee Related
- 2009-02-19 US US12/918,749 patent/US8349828B2/en not_active Expired - Fee Related
- 2009-02-19 ES ES09712156T patent/ES2411930T3/es active Active
- 2009-02-19 RU RU2010138648/04A patent/RU2010138648A/ru unknown
- 2009-02-19 CA CA2713182A patent/CA2713182C/en not_active Expired - Fee Related
- 2009-02-20 AR ARP090100595A patent/AR070455A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
KR101590202B1 (ko) | 2016-01-29 |
CN102015710B (zh) | 2013-04-24 |
WO2009104147A3 (en) | 2009-11-05 |
WO2009104147A2 (en) | 2009-08-27 |
US8349828B2 (en) | 2013-01-08 |
CA2713182A1 (en) | 2009-08-27 |
RU2010138648A (ru) | 2012-03-27 |
EP2257551A2 (en) | 2010-12-08 |
AR070455A1 (es) | 2010-04-07 |
US20100331318A1 (en) | 2010-12-30 |
ES2411930T3 (es) | 2013-07-09 |
TW200940551A (en) | 2009-10-01 |
CA2713182C (en) | 2016-09-13 |
JP5349500B2 (ja) | 2013-11-20 |
EP2257551B1 (en) | 2013-04-10 |
JP2011512398A (ja) | 2011-04-21 |
AU2009215327A1 (en) | 2009-08-27 |
BRPI0907892A2 (pt) | 2015-07-28 |
CN102015710A (zh) | 2011-04-13 |
KR20100124273A (ko) | 2010-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010008922A (es) | Compuestos antibioticos azatriciclicos. | |
CY1118199T1 (el) | Ενωσεις υποκατεστημενης πυραζολο[1,5] πυριμιδινης ως ενδιαμεσα στη συνθεση αναστολεων κινασης trk | |
UA94833C2 (en) | Substituted bicyclolactams | |
MX2010004493A (es) | Compuestos de tropano. | |
PL2069332T3 (pl) | Związki azetydynowe jako antagoniści receptorów oreksynowych | |
MX337516B (es) | Derivados de 1,2,4-tiazolidin-3-ona y uso en el tratamiento del cancer. | |
MX337588B (es) | Metodo para preparar derivados de 5-haloalquil-4,5-dihidroisoxasol . | |
MX2009010552A (es) | Antagonistas de receptor de opioide periferico y usos de los mismos. | |
RS50629B (sr) | Amidni prolek gemcitabina, kompozicije i njihova primena | |
JO3067B1 (ar) | بيرميدينات بيرازولو امينو كمثبطات ل fak | |
TN2009000287A1 (en) | Cyclized derivatives as eg-5inhibitors | |
TW200619206A (en) | Chemokine-binding heterocyclic compound salts, and methods of use thereof | |
MA32956B1 (fr) | Derives de 5-amino-2-(1-hydroxyethyl)-tetrahydropyrane | |
MX2010008713A (es) | Derivados de 5,6-bisaril-2-piridina-carboxamida, su preparacion y su aplicacion en terapeutica como antagonistas de los receptores de la urotensina ii. | |
IL207639A (en) | PyrrollopyrimidineCarboxylate compounds, preparations containing them and their uses | |
MXPA05013751A (es) | Procedimiento e intermediarios para la preparacion de 3-(amino)-3-ciclobutilmetil-2-hidroxi-propionamida o sus sales. | |
IL185545A0 (en) | Method of preparation of pure 4-pyrrolidinophenylbenzyl ether derivatives as maob inhibitors | |
MX2010001938A (es) | Metodos para preparar compuestos basados en 4-fenil-6-(2,2,2-trifl uoro-1-feniletoxi)pirimidina. | |
UA106628C2 (uk) | Метилпіролопіримідинкарбоксаміди | |
WO2008107771A3 (en) | 2',3'-di-o-acyl-5-fluoronucleosides | |
RS53747B1 (en) | FENANTRENON UNITS, COMPOSITIONS AND METHODS | |
IL205083A0 (en) | Process for the preparation of tetranorlabdane derivatives | |
MA32159B1 (fr) | Composes pyrimidylmethylsulfonamides | |
UA27723U (en) | 7-? -hydroxy- ? -(2',4'-dichlorophenoxy)-propyl-8-n-(n'-?-hydroxyethyl)-piperazino-3- methylxanthine revealing hypocholesteremic action | |
UA37264U (en) | Coordination compound of europium (iii) thenoyltrifluoroacetylacetonate with azeloylbis(3,5-dimethylpyrazol) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |